Improved survival in an Asian cohort of young colorectal cancer patients: An analysis of 523 patients from a single institution

International Journal of Colorectal Disease

Volumn 24, Issue 9, 2009, Pages 1075-1083

  Chew, Min Hoe ^a   Koh, Poh Koon ^a   Ng, Kheng Hong ^a   Eu, Kong Weng ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Incidence; Sporadic; Survival; Young colorectal cancer

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ADULT; AGE DISTRIBUTION; ARTICLE; ASIAN; CANCER GRADING; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MUCINOUS CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; SIGNET RING CARCINOMA; SURVIVAL TIME;

ADULT; AGE FACTORS; ASIA; CARCINOEMBRYONIC ANTIGEN; COHORT STUDIES; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; SURVIVAL RATE; YOUNG ADULT;

EID: 68349092800     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-009-0701-7     Document Type: Article

References (34)

1. Atkin WS, Cuzick J, Northover JM et al (1993) Prevention of colorectal cancer by once-only sigmoidoscopy. Lancet 341:736-740
2. Chia KS, Lee HP, Seow A, Shanmugaratnam K (1996) Trends in cancer incidence in Singapore, 1968-1992. Singapore Cancer Registry Report No. 4 p 114
3. Parkin DM, Whelan S, Ferlay J, Raymond L, Young J (1997) Cancer incidence in five continents. IARC Scientific Publication No. 143. IARC, Lyon
4. Surveillance, Epidemiology, and End Results (SEER) Program (2002) Public-use data (1973-1999). http://www.seer.cancer.gov. Cancer Statistics Branch, Surveillance Research Program, DCCPS National Cancer Institute, Bethesda, MD. Accessed August 2008
5. Soliman AS, Bondy ML, Levin B et al (1997) Colorectal cancer in Egyptian patients under 40 years of age. Int J Cancer 71:26-30
6. Yilmazalar T, Zorluoglu A, Ozguc H et al (1995) Colorectal cancer in young adults. Tumori 81:230-233
7. Singh Y, Vaidya P, Hemandas AL et al (2002) Colorectal carcinoma in Nepalese young adults: Presentation and outcome. Gan To Kagaku Ryoho 29(Suppl):223-229
8. Isbister WH (1992) Colorectal cancer below age 40 in the Kingdom of Saudi Arabia. Aust N Z J Surg 62:468-472
9. Taylor MC, Pounder D, Ali-Ridha NH, Bodurtha A, MacMulin EC (1988) Prognostic factors in colorectal carcinoma of young adults. Can J Surg 31:150-153
10. Palmer ML, Herrera L, Petrelli NJ (1991) Colorectal adenocarcinoma in patients less than 40 years of age. Dis Colon Rectum 34:343-346
11. Marble K, Banerjee S, Greenwald L (1992) Colorectal carcinoma in young patients. J Surg Oncol 51:179-182
12. Cusack JC, Giacco GG, Cleary K et al (1996) Survival factors in 186 patients younger than 40 years old with colorectal adenocarcinoma. J Am Coll Surg 183:105-112
13. Adloff M, Arnaud JP, Schloegel M, Thibaud D, Bergamaschi R (1986) Colorectal cancer in patients under 40 years of age. Dis Colon Rectum 29:322-325
14. Beckman EN, Gathright JB, Ray JE (1984) A potentially brighter prognosis for colon carcinoma in the third and fourth decades. Cancer 54:1478-1481
15. Lee PY, Fletcher WS, Sullivan ES, Vetto JT (1994) Colorectal cancer in young patients: Characteristics and outcome. Am Surg 60:607-612
16. Heys SD, Sherif A, Bagley JS, Brittenden J, Smart C, Eremin O (1994) Prognostic factors and survival of patients aged less than 45 years with colorectal cancer. Br J Surg 81:685-688
17. O'Connell JB, Maggard MA, Liu JH, Etzioni DA, Livingston EH, Ko CY (2004) Do young colon cancer patients have worse outcomes? World J Surg 28:558-562
18. Galloway DJ, Burns HJ, Bear H, Jarrett F, Boyle P, Georges WD (1984) Colorectal carcinoma in young adults. Clin Oncol 10:205-211
19. Mitry E, Benhamiche AM, Jouve JL, Clinard F, Finn-Faivre C, Faivre J (2001) Colorectal adenocarcinoma in patients under 45 years of age: comparison with older patients in a well defined French population. Dis Colon Rectum 44(3):380-387
20. Vasen HF, Watson P, Mecklin JP, Lynch HT (1999) New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 116:1453-1456
21. Greene FL, Page DL, Fleming ID et al (eds) (2002) AJCC Cancer staging manual 6th Ed. Springer-Verlag, New York, NY
22. O'Connell JB, Maggard MA, Liu JH et al (2003) The rates of colon and rectal cancers are significantly increasing in young adults. Am J Surg 69:866-872
23. O'Connell JB, Maggard MA, Livingston EH, Yo CK (2004) Colorectal cancer in the young. Am J Surg 187:343-348
24. Chiang JM, Chen MC, Changchien CR, Chen JS, Tang R, Wang JY, Yeh CY, Fan CW, Tsai WS (2003) Favorable influence of age on tumour characteristics of sporadic colorectal adenocarcinoma. Patients 30 years of age or younger may be a distinct patient group. Dis Colon Rectum 46(7):904-910
25. Lin JT, Wang WS, Yen CC, Liu JH, Yang MH, Chao TC, Chen PM, Chiou TJ (2005) Outcome of colorectal carcinoma in patients under 40 years of age. J Gastroenterol Hepatol 20(6):900-905
26. Chung YF, Eu KW, Machin D, Ho JMS, Nyam DCN, Leong AFPK, Ho YH, Seow-Choen F (1998) Young age is not a poor prognostic marker in colorectal cancer. Br J Surg 95:1255-1259
27. Lynch HT, de la Chapelle A (2003) Hereditary Colorectal Cancer. N Engl J Med 348:919-932
28. Gryge R, Kim H, Hsieh ETK et al (2000) Tumour microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med 69:342-347
29. American Cancer Society (2002) Cancer facts and figures 2002. American Cancer Society Surveillance Research, New York (02-250<-No 5008.02:20-6)
30. Marsoni S, International Multicenter Pooled Analysis of Colon Cancer Trials Investigators (2001) Efficacy of adjuvant fluorouracil and leucovorin in stage B2 and C colon cancer. International multicentre pooled analysis of B2 colon cancers trials (IMPACT B2) investigators. Semin Oncol 28:14-19
31. NIH Consensus Conference (1990) Adjuvant therapy for patients with colon and rectal cancer. JAMA 11:1444-1450
32. Locker GY, Hamilton S, Harris J, Jessup JM, Kemeny N et al (2006) ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol 24(33):5313-5327
33. Duffy MJ, van Dalen A, Haglund C, Hansson L, Holinski-Feder E et al (2007) Tumour makers in colorectal cancer: European group on tumour markers (EGTM) guidelines for clinical use. Eur J Cancer 43(9):1348-1360
34. Wiratkapun S, Kraemer M, Seow-Choen F, Ho YH, Eu KW (2001) High preoperative serum carcinoembryonic antigen predicts metastatic recurrence in potentially curative colonic cancer: Results of a five-year study. Dis Colon Rectum 44(2):231-235